Quantification of nivolumab in human plasma by LC-MS/HRMS and LC-MS/MS, comparison with ELISA

Millet, A; Khoudour, N; Bros, P; Lebert, D; Picard, G; Machon, C; Goldwasser, F; Blanchet, B; Guitton, J

Guitton, J (corresponding author), Hosp Civils Lyon, Ctr Hosp Lyon Sud, Ctr Biol Sud, Lab Pharmacotoxicol, F-69495 Pierre Benite, France.

TALANTA, 2021; 224 ():

Abstract

Nivolumab is a fully human immunoglobulin G4 used for the treatment of several advanced solid cancers as immune checkpoint inhibitors. There are some ......

Full Text Link